By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has issued a call notice to holders of its outstanding warrants, the firm said in a filing with the US Securities and Exchange Commission today.

The firm said that each outstanding warrant will continue to be exercisable for preferred stock at an exercise price of $12.50 per share until the close of business on April 27, 2010. On April 28, 2010, any unexercised warrants will be terminated and no longer be exercisable, according to the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.